7.1 Tennessee CSMD Statutory Mandates & Dispenser Reporting
Key Takeaways
- Under the Controlled Substance Monitoring Act of 2002 (T.C.A. Title 53, Chapter 10, Part 3) and Tenn. Comp. R. & Regs. Chapter 1140-11, the Tennessee Controlled Substance Monitoring Database (CSMD) operates as an electronic surveillance tool to curb diversion, misuse, and overdoses while safeguarding legitimate medical care.
- Every licensed dispenser—including retail pharmacies, institutional outpatient pharmacies, and out-of-state mail-order pharmacies shipping into Tennessee—must report all dispensed Schedule II, III, IV, and V controlled substances, as well as state-monitored non-controlled drugs and gabapentin (scheduled as a Schedule V controlled substance in Tennessee).
- Tennessee mandates that controlled substance dispensing data be transmitted to the CSMD no later than the close of business on the business day immediately following the day the prescription was dispensed (the strict 'next business day' standard).
- Mandatory data submissions follow the American Society for Automation in Pharmacy (ASAP) standard and require 15+ discrete data fields, including prescriber DEA/NPI, patient demographics, drug NDC, metric quantity, estimated days supply, prescription number, dates written/filled, refill number, and source of payment.
- Licensed practice sites dispensing zero controlled substances during a reporting period must submit a zero report, and knowing failure to submit, fraudulent submissions, or chronic delinquency subject the dispenser to civil monetary penalties and professional licensure discipline under T.C.A. § 53-10-308.
7.1 Tennessee CSMD Statutory Mandates & Dispenser Reporting
Quick Answer: Under the Controlled Substance Monitoring Act of 2002 (T.C.A. § 53-10-301 et seq.) and Tenn. Comp. R. & Regs. Chapter 1140-11, all licensed dispensers in Tennessee (and out-of-state mail-order pharmacies dispensing into Tennessee) must report all dispensed Schedule II, III, IV, and V controlled substances, plus state-monitored substances including gabapentin (classified as a Schedule V controlled substance in Tennessee). Reports must be transmitted electronically no later than the close of business on the business day immediately following the day of dispensing (the "next business day" standard). Dispensers that dispense no controlled substances must file a zero report. Knowing failure to report or fraudulent reporting triggers civil monetary penalties up to $100 per day and formal Board disciplinary sanctions under T.C.A. § 53-10-308.
1. Statutory Architecture & Legislative Evolution
The Tennessee Controlled Substance Monitoring Database (CSMD) was formally established by the Tennessee General Assembly under the Controlled Substance Monitoring Act of 2002, codified at Tennessee Code Annotated (T.C.A.) Title 53, Chapter 10, Part 3 (§§ 53-10-301 through 53-10-312). The legislative declaration of public policy set forth in T.C.A. § 53-10-301 establishes a dual statutory mandate:
- To provide a centralized, electronic repository of dispensing data for controlled substances to assist healthcare practitioners in clinical decision-making, mitigate polypharmacy, and prevent substance use disorders, drug overdoses, and drug diversion; and
- To provide a secure investigative resource for professional licensing boards and law enforcement agencies investigating unauthorized distribution, doctor shopping, and illicit pill mills without unduly burdening lawful pharmaceutical care.
Legislative Evolution: 2002 to Present
Over the past two decades, Tennessee's CSMD statutes have undergone major legislative overhauls reflecting the escalation of the opioid epidemic:
- 2002 Original Enactment: Created a voluntary-access database with weekly dispenser reporting.
- Tennessee Prescription Safety Act of 2012: Made prescriber and dispenser registration mandatory, instituted mandatory queries before initiating chronic opioids and benzodiazepines, increased reporting frequency to at least once every seven (7) days, and established criminal penalties for unauthorized database queries.
- Tennessee Prescription Safety Act of 2016 (Public Chapter 1002): Transferred operational and technical administration to the Department of Health, accelerated reporting frequency to daily (no later than close of business the following business day), expanded delegate access, and tightened mandatory checking triggers.
- Tennessee Together (2018 Public Chapters 1039 & 1040): Scheduled gabapentin as a Schedule V controlled substance under Tennessee state law (effective July 1, 2018), codified strict acute opioid dosage limits (a 3-day/180 MME default under T.C.A. § 63-1-164(b), a 10-day/500 MME tier under § 63-1-164(d)(2), and a 30-day/1,200 MME tier under § 63-1-164(d)(3) and (d)(4), each tied to Morphine Milligram Equivalents), and required real-time EHR integration.
2. CSMD Advisory Committee & Regulatory Oversight
Administrative oversight of the database is governed jointly by the Tennessee Department of Health and the Controlled Substance Database Advisory Committee, established pursuant to T.C.A. § 53-10-303 and Tenn. Comp. R. & Regs. Chapter 1140-11.
Committee Composition
The Advisory Committee serves as a specialized regulatory and consultative body composed of licensed healthcare practitioners appointed by the Governor and their respective professional licensing boards:
- Representatives from the Tennessee Board of Pharmacy (including active community and hospital pharmacists);
- Representatives from the Tennessee Board of Medical Examiners (allopathic physicians);
- Representatives from the Tennessee Board of Osteopathic Examination;
- Representatives from the Tennessee Board of Nursing (advanced practice registered nurses);
- Representatives from the Committee on Physician Assistants;
- Representatives from the Tennessee Board of Dentistry;
- Representatives from the Tennessee Board of Optometric Practice; and
- Representatives from the Tennessee Board of Veterinary Medical Examiners.
Core Committee Responsibilities
Under T.C.A. § 53-10-303, the Committee is statutorily charged with:
- Establishing technical transmission protocols and data collection standards conforming to national models (ASAP formats);
- Overseeing data security, encryption protocols, and user authentication procedures;
- Reviewing dispenser compliance rates, delinquency reports, and automated error-correction logs;
- Formulating recommendations to licensing boards regarding educational initiatives, clinical alert thresholds, and potential disciplinary referrals for persistent non-reporting dispensers; and
- Reviewing and approving clinical exception parameters and interstate data-sharing compacts.
3. Scope of Monitored Substances & Gabapentin Classification
Under T.C.A. § 53-10-302 and § 53-10-305, reporting obligations extend to all pharmaceutical dosage forms and formulations categorized within:
┌─────────────────────────────────────────────────────────────────────────────┐
│ CSMD REPORTABLE SUBSTANCES HIERARCHY │
├──────────────────────────┬──────────────────────────────────────────────────┤
│ Classification Category │ Statutory Scope & Specific Inclusions │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Schedule II Controlled │ All opioids (e.g., oxycodone, hydrocodone, │
│ Substances │ fentanyl, morphine, methadone, oxymorphone), │
│ │ stimulants (e.g., amphetamine salts, │
│ │ methylphenidate, lisdexamfetamine), barbiturates.│
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Schedule III Controlled │ Buprenorphine formulations (Suboxone, Subutex), │
│ Substances │ anabolic steroids, dronabinol, ketamine, codeine │
│ │ combination products (≤90 mg/dosage unit). │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Schedule IV Controlled │ Benzodiazepines (alprazolam, clonazepam, │
│ Substances │ lorazepam, diazepam), Z-drugs (zolpidem, │
│ │ eszopiclone), tramadol, carisoprodol (Soma), │
│ │ modafinil, phenobarbital. │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Schedule V Controlled │ Pregabalin (Lyrica), lacosamide (Vimpat), │
│ Substances (Federal) │ diphenoxylate/atropine (Lomotil), codeine cough │
│ │ syrups (e.g., Promethazine with Codeine). │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Tennessee State-Specific │ GABAPENTIN (Neurontin and generic formulations). │
│ Schedule V Addition │ Classified as Schedule V in TN under Public │
│ │ Chapter 1040 / T.C.A. § 39-17-415 (July 1, 2018). │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Monitored Non-Scheduled │ Any additional drug identified by the Committee │
│ Substances │ exhibiting widespread potential for abuse or │
│ │ drug-induced respiratory depression. │
└──────────────────────────┴──────────────────────────────────────────────────┘
The Gabapentin Mandate (Exam Alert)
Candidates often confuse federal and state controlled substance schedules. Federally, gabapentin remains a non-controlled legend drug. However, in Tennessee, pursuant to T.C.A. § 39-17-415 and T.C.A. § 53-10-302, gabapentin was reclassified as a Schedule V controlled substance. Consequently:
- Every dispense of gabapentin in Tennessee must be reported to the CSMD.
- Out-of-state mail-order pharmacies shipping gabapentin to Tennessee residents must report each transaction to the Tennessee CSMD.
- Gabapentin prescriptions are subject to Schedule V legal restrictions (e.g., valid for a maximum of 6 months from the date of issuance, maximum of 5 refills, secure storage, and strict transfer limits).
4. Dispenser Reporting Frequency: The "Next Business Day" Standard
Under T.C.A. § 53-10-305(a) and Tenn. Comp. R. & Regs. 1140-11-.03, dispenser reporting is subject to a strict, immutable statutory timeline:
[!IMPORTANT] Statutory Reporting Timeline: Each dispenser shall submit the required information to the database for all controlled substances and monitored drugs dispensed no later than the close of business on the business day immediately following the day the controlled substance was dispensed.
Defining "Close of Business on the Following Business Day"
To apply this rule correctly on the MPJE, candidates must understand how weekends, operating hours, and legal holidays operate under the rule:
- Standard Weekday Dispensing: If a controlled substance is dispensed on a Monday at 11:00 AM, the dispensing transaction must be transmitted to the CSMD no later than the close of business on Tuesday.
- Weekend Dispensing: If a controlled substance is dispensed on a Friday afternoon or Saturday, and the pharmacy is closed on Sunday, the record must be transmitted no later than the close of business on Monday (the next business day).
- Legal Holidays: If a pharmacy dispenses on Wednesday preceding Thanksgiving, and the pharmacy is closed on Thursday (Thanksgiving), the report is due no later than the close of business on Friday.
- 24-Hour Pharmacies: For pharmacies operating continuously 24 hours a day, 7 days a week, "close of business" is administratively defined as 11:59:59 PM Central Time of the following calendar day.
┌─────────────────────────────────────────────────────────────────────────────┐
│ CSMD REPORTING TIMELINE WORKFLOW │
├──────────────────────────┬──────────────────────────────────────────────────┤
│ Dispense Day │ Statutory Reporting Deadline │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Monday │ Close of business on Tuesday │
│ Tuesday │ Close of business on Wednesday │
│ Wednesday │ Close of business on Thursday │
│ Thursday │ Close of business on Friday │
│ Friday │ Close of business on Monday │
│ Saturday │ Close of business on Monday │
│ Sunday (if open) │ Close of business on Monday │
│ Day Preceding Holiday │ Close of business on Next Operating Business Day │
└──────────────────────────┴──────────────────────────────────────────────────┘
5. Comprehensive Roster of Required ASAP Data Elements
Under T.C.A. § 53-10-305(b) and Board Rule 1140-11-.04, dispensers must submit records using the standard electronic format established by the American Society for Automation in Pharmacy (ASAP) (currently ASAP Telecommunications Format for Controlled Substances, Version 4.2 or higher). Each transmission must capture the following mandatory fields:
┌─────────────────────────────────────────────────────────────────────────────┐
│ MANDATORY CSMD REPORTING DATA FIELDS │
├──────────────────────┬──────────────────────────────────────────────────────┤
│ Category │ Required Data Elements │
├──────────────────────┼──────────────────────────────────────────────────────┤
│ Prescriber Identifiers│ 1. Prescriber DEA Registration Number │
│ │ 2. Prescriber National Provider Identifier (NPI) │
├──────────────────────┼──────────────────────────────────────────────────────┤
│ Patient Demographics │ 3. Patient Full Legal Name (Last, First, Middle) │
│ │ 4. Patient Residential Address (Street, City, State, │
│ │ ZIP Code) │
│ │ 5. Patient Date of Birth (DOB - YYYYMMDD) │
│ │ 6. Patient Gender / Sex │
│ │ 7. Patient Telephone Number │
├──────────────────────┼──────────────────────────────────────────────────────┤
│ Drug & Dispensing │ 8. National Drug Code (NDC) of the product dispensed │
│ Metrics │ 9. Metric Quantity Dispensed (e.g., number of tabs, │
│ │ milliliters of oral liquid) │
│ │ 10. Estimated Days Supply │
│ │ 11. Prescription Serial Number (Rx Number) │
│ │ 12. Date Prescription Written by Prescriber │
│ │ 13. Date Prescription Dispensed (Date Filled) │
│ │ 14. Refill Number (e.g., 00 for new fill, 01, etc.) │
├──────────────────────┼──────────────────────────────────────────────────────┤
│ Dispenser Information│ 15. Dispenser DEA Registration Number │
│ │ 16. Dispenser NPI / Pharmacy License Number │
├──────────────────────┼──────────────────────────────────────────────────────┤
│ Financial / Payment │ 17. Source of Payment / Payment Method Code: │
│ Data │ • Cash / Self-Pay │
│ │ • Commercial / Private Third-Party Insurance │
│ │ • Medicaid / TennCare │
│ │ • Medicare (Part D or Medicare Advantage) │
│ │ • Military / VA / Tricare / Workers' Comp │
└──────────────────────┴──────────────────────────────────────────────────────┘
[!NOTE] Tracking the source of payment is critical for forensic surveillance. Empirical DEA and TBI investigations demonstrate that patients diverting controlled substances frequently bypass commercial insurance and pay cash to avoid insurer drug utilization review (DUR) quantity blocks or cross-pharmacy fill alerts.
6. Statutory Dispensers Exemptions from Reporting
Not every act of administering or dispensing a controlled substance triggers a CSMD transmission. Under T.C.A. § 53-10-304, the following clinical situations are statutorily exempt from the dispenser reporting mandate:
| Setting / Clinical Situation | Exemption Rationale | Governing Statute |
|---|---|---|
| Inpatient Hospital Administration | Controlled substances administered directly to a patient admitted to a licensed hospital (inpatient chart orders). | T.C.A. § 53-10-304(1) |
| Inpatient Hospice Facility | Controlled substances administered directly to an inpatient in a licensed hospice residential facility. | T.C.A. § 53-10-304(2) |
| Outpatient Immediate Administration | Controlled substances administered directly to a patient in an outpatient clinic or emergency department where the quantity is for immediate consumption (e.g., single sublingual or IV dose). | T.C.A. § 53-10-304(3) |
| Emergency Department Short Supply | A licensed physician dispensing a non-refillable acute supply of a controlled substance directly to an emergency department patient in an amount not exceeding forty-eight (48) hours. | T.C.A. § 53-10-304(4) |
| Veterinary Short Administration | A licensed veterinarian administering or dispensing a controlled substance to an animal patient in an amount not exceeding forty-eight (48) hours. | T.C.A. § 53-10-304(5) |
| Licensed Narcotic Treatment Programs | Federally certified Opioid Treatment Programs (OTPs) dispensing methadone or buprenorphine for maintenance/detoxification under 42 CFR Part 2 (governed by federal substance use privacy rules). | T.C.A. § 53-10-304(6) |
[!WARNING] Discharge Prescriptions Are NOT Exempt: If a hospital outpatient pharmacy or retail pharmacy fills a controlled substance discharge prescription for a patient leaving the hospital to take home, that transaction is a traditional outpatient dispense and MUST be reported to the CSMD within the standard next-business-day timeline!
7. Zero-Reporting Mandates & Automated Transmission Protocols
To ensure database integrity and verify that licensed pharmacies are not experiencing network outages or concealing dispensing activity, Tennessee law enforces an affirmative Zero-Reporting Rule.
The Zero-Reporting Obligation (Board Rule 1140-11-.03(2))
- If a pharmacy practice site holds an active Tennessee retail or institutional outpatient pharmacy license and does not dispense any Schedule II, III, IV, or V controlled substances or monitored drugs during a normal business day, the dispenser must submit an electronic zero report.
- The zero report must be submitted via the CSMD vendor portal (or automated ASAP 4.2 zero-report batch transaction) no later than the close of business on the following business day.
- Submitting a zero report informs the Department of Health that the practice site was operational but engaged in zero controlled substance dispensing, distinguishing lawful non-dispensing from system failures or deliberate non-compliance.
Exemption Waivers from Zero Reporting
A licensed practice site may apply in writing to the Department of Health / CSMD Director for a formal Waiver of Reporting Requirements if:
- The practice site never stocks, orders, possesses, or dispenses any Schedule II through V controlled substances or monitored drugs (e.g., specialized non-sterile compounding pharmacies that formulate exclusively non-controlled hormone therapies, or nuclear pharmacies that compound solely radiopharmaceuticals); or
- The pharmacy provides documentation establishing good-cause technical impossibility (e.g., prolonged catastrophic power loss from a tornado or flood), in which case a temporary hardship extension may be granted.
8. Enforcement, Penalties & Disciplinary Sanctions
Compliance with CSMD reporting mandates is rigorously audited by the Tennessee Department of Health and Board of Pharmacy investigators. Under T.C.A. § 53-10-308 and Tenn. Comp. R. & Regs. 1140-11-.07, severe penalties attach to non-compliance:
┌─────────────────────────────────────────────────────────────────────────────┐
│ CSMD REPORTING ENFORCEMENT MATRIX │
├──────────────────────────┬──────────────────────────────────────────────────┤
│ Violation Level │ Statutory & Administrative Sanctions │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Unintentional Technical │ Automated electronic deficiency notice issued. │
│ Transmission Error │ Pharmacist/site has 14 calendar days to correct │
│ │ and resubmit rejected data batches. │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Knowing Failure to Submit│ Civil monetary penalties of up to $100 per day │
│ Daily Dispensing Data │ for each calendar day of non-reporting. │
│ │ (T.C.A. § 53-10-308(a)). │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Chronic Delinquency / │ Formal Board of Pharmacy Notice of Charges. │
│ Pattern of Non-Reporting │ Administrative fines up to $1,000 per violation │
│ │ under Rule 1140-08, plus reprimand, probation, │
│ │ or practice site license suspension. │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Intentional Fraudulent │ Class D Felony under T.C.A. § 53-10-308(b) for │
│ Submission / Tampering │ submitting falsified or forged dispensing records│
│ │ to deceive regulatory authorities. │
└──────────────────────────┴──────────────────────────────────────────────────┘
Pharmacist-in-Charge (PIC) Ultimate Liability
Under Tenn. Comp. R. & Regs. 1140-03-.14, the Pharmacist-in-Charge (PIC) bears primary supervisory responsibility for establishing and maintaining written policies and automated technical protocols ensuring timely, daily CSMD reporting. While an individual staff pharmacist or pharmacy technician may initiate the daily batch transmission, the PIC is individually accountable to the Board if the pharmacy system fails to report or exhibits persistent transmission delinquencies.
9. Practical Exam Scenarios
Scenario 1: The Holiday Dispensing Dilemma
Case: Volunteer Pharmacy dispenses 45 controlled substance prescriptions on Wednesday afternoon before Thanksgiving. The pharmacy is closed on Thursday for Thanksgiving Day, reopens on Friday from 9:00 AM to 6:00 PM, operates on Saturday from 9:00 AM to 1:00 PM, and is closed on Sunday. When is the statutory reporting deadline for Wednesday's dispensing records? Legal Analysis: Under T.C.A. § 53-10-305(a), records must be submitted no later than the close of business on the business day immediately following the dispensing day. Because Thursday is a recognized legal holiday on which the facility is closed, Friday is the immediate following business day. Therefore, the Wednesday dispenses must be transmitted no later than close of business (6:00 PM) on Friday.
Scenario 2: Out-of-State Mail-Order Gabapentin Dispense
Case: Apex Specialty Mail Pharmacy, located in Dallas, Texas, holds an active out-of-state pharmacy license issued by the Tennessee Board of Pharmacy. Apex dispenses a 90-day supply of gabapentin 600 mg tablets to a patient residing in Knoxville, Tennessee. The dispensing pharmacist in Texas notes that gabapentin is not a controlled substance under federal law or Texas state law and chooses not to report the transaction to the Tennessee CSMD. Legal Analysis: Under T.C.A. § 39-17-415 and T.C.A. § 53-10-305, gabapentin is a Schedule V controlled substance in Tennessee. Any pharmacy—regardless of physical location—that holds a Tennessee license and dispenses a controlled substance delivered into Tennessee must report the dispense to the Tennessee CSMD by the next business day. Apex and its PIC are in violation of Tennessee law and subject to civil penalties and disciplinary action against Apex's Tennessee license.
Scenario 3: Hospital Discharge Dispensing vs. Inpatient Orders
Case: St. Jude Memorial Hospital operates an inpatient central pharmacy and an adjoining outpatient employee/discharge retail pharmacy under separate practice site licenses. A physician enters two orders for a patient: (1) Morphine 2 mg IV push administered in the intensive care unit, and (2) Oxycodone 5 mg tablets #20 to take home upon discharge, filled by the discharge pharmacy. Which transaction must be reported to the CSMD? Legal Analysis: Under T.C.A. § 53-10-304, controlled substances administered directly to an inpatient in a licensed hospital (the IV morphine) are statutorily exempt from CSMD reporting. However, the discharge prescription filled by the outpatient pharmacy is an outpatient dispense intended for home administration and is not exempt. It must be reported to the CSMD no later than close of business on the following business day.
Under the Tennessee Controlled Substance Monitoring Act of 2002 (T.C.A. § 53-10-305) and Board Rule 1140-11, what is the mandatory statutory timeline for a licensed community pharmacy to submit controlled substance dispensing data to the CSMD?
A community pharmacy in Nashville dispenses gabapentin 300 mg capsules to a patient. Which of the following statements accurately characterizes the legal status of gabapentin and the pharmacist's CSMD reporting obligation under Tennessee law?
Which of the following controlled substance dispensing scenarios is statutorily EXEMPT from reporting to the Tennessee Controlled Substance Monitoring Database under T.C.A. § 53-10-304?
A newly licensed independent pharmacy practice site in Chattanooga dispenses only non-controlled maintenance medications during its first week of operation and dispenses zero controlled substances. Under Tennessee Board Rule Chapter 1140-11, what is the legal obligation of the Pharmacist-in-Charge (PIC)?